Market cap
₹602 Cr
Revenue (TTM)
₹147 Cr
P/E Ratio
29.3
P/B Ratio
6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 40.04 | 24.52 | -- |
| EBIT | -- | -- | 47.00 | 38.67 | -- |
| Net Profit | -- | -- | 54.76 | 41.87 | -- |
| EPS | -- | -- | 21.33 | 30.81 | -- |
| Book Value | -- | -- | 118.55 | 89.27 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| 16.60 | -- | 17.77 | -- | -- |
| Net Margin
| 12.54 | -- | 13.86 | -- | -- |
| Return on equity
| 46.57 | -- | 20.38 | -- | -- |
| Return on Capital
| 61.80 | -- | 27.22 | -- | -- |
| Return on Assets
| 25.80 | -- | 16.69 | -- | -- |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | -- |
Profitability
ROCE
27.22
Lower than Peers by 2.32
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
27.22
|
--
|
--
|
--
|
--
|
|
Peer Median
|
29.54
|
28.06
|
23.90
|
26.40
|
--
|
ROE
20.38
Lower than Peers by 2.07
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
20.38
|
--
|
--
|
--
|
--
|
|
Peer Median
|
22.46
|
20.26
|
19.84
|
21.69
|
--
|
ROA
16.69
Higher than Peers by 3.34
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
16.69
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.35
|
14.11
|
14.13
|
15.09
|
--
|
EBIT Margin
17.77
Lower than Peers by 0.76
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
17.77
|
--
|
--
|
--
|
--
|
|
Peer Median
|
18.52
|
19.37
|
16.48
|
18.38
|
--
|
Net Margin
13.86
Higher than Peers by 0.31
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
13.86
|
--
|
--
|
--
|
--
|
|
Peer Median
|
13.55
|
15.11
|
13.91
|
15.46
|
--
|
Cash Profit Margin
16.56
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
16.56
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.40
|
3.56
|
8.47
|
11.52
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-3.34
|
1.53
|
-2.19
|
3.62
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.09
|
6.67
|
--
|
3.62
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.04
|
0.03
|
0.03
|
0.08
|
--
|
Current Ratio
3.59
Higher than Peers by 1.89
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
3.59
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.70
|
1.64
|
1.57
|
1.38
|
--
|
Quick Ratio
2.89
Higher than Peers by 1.85
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
2.89
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.04
|
1.35
|
1.16
|
0.90
|
--
|
Interest Coverage
141.22
Higher than Peers by 97.26
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
141.22
|
--
|
--
|
--
|
--
|
|
Peer Median
|
43.96
|
42.69
|
32.13
|
44.18
|
--
|
Operating Efficiency
Debtors to sales
23.01
Higher than Peers by 14.55
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
23.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
8.46
|
7.80
|
7.36
|
6.51
|
--
|
Asset Turnover
1.19
Higher than Peers by 0.13
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
1.19
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.06
|
1.01
|
1.04
|
0.96
|
--
|
Receivable days
83.97
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
83.97
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
39.61
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
39.61
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
117.65
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
117.65
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
5.93
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
5.93
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
22.77
Lower than Peers by 6.79
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
22.77
|
--
|
--
|
--
|
--
|
|
Peer Median
|
29.56
|
51.77
|
52.73
|
43.57
|
--
|
Price / Book Value
4.64
Lower than Peers by 2.02
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
4.64
|
--
|
--
|
--
|
--
|
|
Peer Median
|
6.66
|
10.70
|
8.05
|
8.89
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.17
|
1.17
|
1.39
|
1.52
|
--
|
EV/EBITDA
14.18
Lower than Peers by 16.38
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
14.18
|
--
|
--
|
--
|
--
|
|
Peer Median
|
30.57
|
43.63
|
40.96
|
35.09
|
--
|
Market Cap
468
Lower than Peers by 21,606
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Influx Healthtech
|
468
|
--
|
--
|
--
|
--
|
|
Peer Median
|
22,073
|
52,262
|
46,433
|
43,509
|
--
|